L
LIH Investment & Management
LIH Investment & Management owns and operates rehabilitation hospitals
About LIH Investment & Management
LIH Investment & Management operates LIH Olivia's Place, a pediatric therapy provider in China. The company was established after the founders, Nelson and Quynh Chow, sought high-quality therapy services for their daughter, Olivia, who has Down's Syndrome. This personal journey led them to create a service that was needed in China. Nelson Chow has a background in semiconductor engineering with experience in starting successful companies, holding numerous patents in the field. His co-founder, Quynh Chow, holds an MBA and has a professional history in banking and consulting.
LIH Olivia's Place delivers multidisciplinary pediatric therapy services for children of all ages and abilities. The business serves its clients through three main channels: pediatric therapy consulting, educational outreach, and foundation initiatives. The consulting services include occupational, physical, and speech therapies, as well as psychology services, applied behavior analysis (ABA), and learning support, offered in both English and Chinese. Through its educational outreach, the company's clinical staff provides classes and training to the broader community, including schools, hospitals, and local therapists. Revenue is generated from these therapy and consulting services.
A key component of the business is the Olivia's Foundation, which raises funds to subsidize care for families who cannot afford the services, aiming to make pediatric therapy universally available in China. This integrated model allows the company to operate as a social enterprise, combining a for-profit service with a non-profit mission. The company's services are primarily aimed at families, but it also collaborates with educational and medical institutions to extend its impact.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Dongcheng District, China
- Employees
- 53
- Open positions
- None listed
- Dealroom signal
- 27.4/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Hospital, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AEquity / VC | Feb 2017 | $5.5M | $22M | Qiming Venture Partners | — |
| SERIES A✓Equity / VC | Jun 2016 | $12M | $47M | Qiming Venture Partners | — |
Growth signals
Latest recorded traffic for LIH Investment & Management is 190 monthly website visits, up 280% over the last three months. LIH Investment & Management's team declined 10.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about LIH Investment & Management on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LIH Investment & Management’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








